Cyclosporine in glomerular disease

Seminars in Nephrology

Volumn 16, Issue 6, 1996, Pages 548-554

  Mowry, Jeanne A ^a,b   McCarthy, Ellen T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PREDNISONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHINGOID SYNDROME; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MULTICENTER STUDY; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; CHILD; CLINICAL TRIALS; CYCLOSPORINE; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROGNOSIS; RECURRENCE;

EID: 0029854997     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Makker SP, Hermann W: The idiopathic nephrotic syndrome of childhood: A clinical reevaluation of 148 cases. Am J Dis Child 127:830-837, 1974
2. Korbet S, Schwanz M, Lewis E: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23:773-783, 1994
3. Tejani A: Relapsing nephrotic syndrome. Nephron 45:81-85, 1987
4. Mendoza SA, Tune BM: Treatment of childhood nephrotic syndrome. J Am Soc Nephrol 3:889-894, 1992
5. McDonald J, Murphy AV, Arneil GC: Long-term assessment of cyclophosphamide therapy for nephrosis. Lancet 2:980-982, 1974
6. Tanaka R, Yoshikawa N, Kitano Y, et al: Long-term cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 7:249-252, 1993
7. Kitano Y, Yoshikawa N, Tanaka R, et al: Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 4:474-474, 1990
8. Tejani A, Butt K, Trachtman H, et al: Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33:729-734, 1988
9. Niaudet P, Broyer M, Habib R: Treatment of idiopathic nephrotic syndrome with Cyclosporine A in children. Clin Nephrol 35:S31-S36, 1991
10. Meyrier A, Niaudet P, Brodehl J: Optimal Use of Sandimmune in Nephrotic Syndrome. Berlin, Springer-Verlag, 1992, pp 1-34
11. Hulton SA, Neuhaus TJ, Dillon MJ, et al: Long-term cyclosporine A treatment of minimal change nephrotic syndrome of childhood. Pediatr Nephrol 8:401-403, 1994
12. Maher ER, Sweny P, Chappel M. et al: Cyclosporine in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 3:728-732, 1988
13. Meyrier A, Collaborative Group of the Sociéte de Néphrologie: Cyclosporin in the treatment of nephrosis. Am J Nephrol 9:565-571, 1989
14. Meyrier A, Condamin C, Broneer D, and the Collaborative Group of the French Society of Nephrology: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal change disease and focal segmental glomerulosclerosis. Clin Nephrol 35:537-542, 1991
15. Niaudet P, French Society of Pediatric Nephrology: Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicenter randomized controlled trial. Pediatr Nephrol 6:1-3, 1992
16. Ponticelli C, Edefonti A, Ohio L, et al: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing nephrotic syndrome: A multicenter randomized controlled trial. Nephrol Dial Transplant 8:1326-135, 1993
17. Niaudet P, Habib R: Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 5:1049-1056, 1994
18. Niaudet P, French Society of Pediatric Nephrology: Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125:981-986, 1994
19. Gregory MJ, Smoyer WE, Sedman A, et al: Long-term cyclosporin therapy for pediatric nephrotic syndrome. A clinical and histologie analysis. J Am Soc Nephrol 7:543-549, 1996
20. Delaney MP, Dukes DC, Edmunds ME: Cyclosporin A in refractory idiopathic nephrotic syndrome: 5 years clinical experience. Postgrad Med J 70:891-894, 1994
21. Ponticelli C, Rizzoni G, Edefonts A, et al: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377-1384, 1993
22. Tejani A, Lieberman K: A randomized placebo controlled double blind trial of cyclosporine in steroid resistant idiopathic focal segmental glomerulosclerosis in children. A report of the New York, New Jersey Pediatric Nephrology Collaborative Study Group. J Am Soc Nephrol 4:289, 1993 (abstr)
23. Tejani A, Suthanthiran M, Pomerantz A: A randomized controlled trial of low-dose prednisone and cyclosporine versus high-dose prednisone in nephrotic syndrome of children. Nephron 59:96-99, 1991
24. Leumann EP, Briner J, Donckerwoldke RAM, et al: Recurrence of focal segmental glomerulosclerosis in the transplanted kidney. Nephron 25:65-71, 1980
25. Senguttuvan P, Cameron JS, Hartley B, et al: Recurrence of focal segmental glomerulosclerosis (FSGS) in 58 renal allografts from a single centre: Analysis of risk factors for recurrence. Pediatr Nephrol 4:21, 1990
26. Artero M, Biava C, Amend W, et al: Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 92:375-83, 1992
27. Morales JM, Andres A, Prieto C, et al: Ciclosporin-induced partial and transient improvement of nephrotic syndrome in recurrent focal segmental glomerulosclerosis. Nephron 53:283-284, 1989
28. Ingulli E, Tejani A, Butt KH, et al: High-dose Cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation. Transplantation 49:219-221, 1990
29. Srivastava RN, Kalia A, Travis LB, et al: Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine. Pediatr Nephrol 8:94-95, 1994
30. Mowry J, Marik J, Cohen A, et al: Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. Trans Proc 25:1345-1346, 1993
31. Savin VJ, Sharma R, Sharma M, McCarthy ET, et al: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883, 1996
32. Donadio JV, Torres VE, Velosa JA, et al: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
33. DeSanto NG, Capodicasa G, Giordano C: Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporine. Am J Nephrol 7:74-76, 1987
34. Rostoker G, Belghiti D, Ben Maadi A, et al: Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 63:335-341, 1993
35. Gausch A, Suranyi M, Newton L, et al: Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis 20:472-481, 1992
36. Cattran DC, Greenwood C, Ritchie S, et al: Canadian Glomerulonephritis Study Group. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47:1130-1135, 1995
37. van der Peet J, Arisz L, Brenljens JRG, et al: The clinical course of IgA nephropathy in adults. Clin Nephrol 8:335-340, 1977
38. Cattran DC, Dossetor J, Halloran PF, et al: Cyclosporin in glomerulonephritis: A pilot study, in Schindler R (ed): Cyclosporin in Auto-Immune Disease. Berlin, Springer, 1985, pp 311-315
39. Lai KM, Lai F, Vallance-Owen J: A short-term controlled trial of cyclosporine A in IgA nephropathy. Transplant Proc 20:297-303, 1988 (suppl 4)
40. Watzon AR: Cyclosporine therapy for chronic glomerulonephritis. Clin Nephrol 25:273-274, 1986
41. Lagrue G, Laurent J, Robeva R: Membranoproliferative glomerulonephritis associated with Buckley's syndrome, treated with Cyclosporin. Nephron 44:382-383, 1986
42. Zietse R, Wanting GJ, Kramer P, et al: Effects of Cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sei 82:641-650, 1992
43. Zietse R, Wenting GJ, Kramer P, et al: Contrasting response to Cyclosporin in refractory nephrotic syndrome. Clin Nephrol 31:22-25, 1989
44. Erbay B, Karatan O, Duman N, et al: The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Trans Proc 20:289-292, 1988 (suppl 4)
45. Noyan A, Anarat A, Tuncer I, et al: Efficacy and side effects of Cyclosporin A in nephrotic syndrome of childhood. Nephron 70:410-415, 1995
46. Halloran PF, Cole EH, Bookman AA, et al: Possible beneficial effect of ciclosporin in some cases of severe systemic lupus erythematosus, in Schindler R (ed): Ciclosporin in Autoimmune Disease. Berlin, Springer, 1985, pp 356-360
47. Deteix P, Le Francois N, Labille M, et al: Open therapeutic trial of ciclosporin in systemic lupus erythematosus. Preliminary results in 4 patients, in Schindler R (ed): Ciclosporin in Autoimmune Disease. Berlin, Springer, 1985, pp 361-365
48. Favre H, Miescher A, Huang YP, et al: Ciclosporine in the treatment of lupus nephritis. Am J Nephrol 9:57-60, 1989 (suppl)
49. LeFrancois N, Deteix P, Labille M, et al: Treatment of systemic lupus with cyclosporin A: A patient with a 1-yr follow-up. Kidney Int 26:225, 1984
50. Hussein MM, Mooij JM, Roujouleh: Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 40:160-163, 1993
51. Balletta M, Sabella D, Magri P, et al: Ciclosporin plus steroids versus steroids alone in the treatment of lupus nephritis, in Sess A, Meroni M, Battini G (eds): Systemic Lupus Erythematosus: Renal Vasculitis. Contrib Nephrol 95:129-130, 1992
52. Schwanz MM, Kawala K, Roberts JL, et al: Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol 4:301-311, 1984
53. Feutren G, Querin S, Noel LH, et al: Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 111:1063-1068, 1987
54. Radhakrishnan J, Kunis CL, D'Agati B, et al: Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 42:147-154, 1994
55. Querin S, Schurch W, Beaulieu R: Ciclosporin in Goodpasture's syndrome. Nephron 60:355-359, 1992
56. Allen NB, Caldwell DS, Rice JR, et al: Cyclosporin A therapy for Wegener's granulomatosis. Adv Exp Med Biol 336:473-476, 1993
57. Borleffs JC, van der Zwan JC: Cyclosporin in Wegener's granulomatosis with renal failure. Ann Rheum Dis 49:568, 1990
58. Gremmel F, Druhl W, Schmidt P, Graninger W: Cyclosporin in Wegener's granulomatosis. Ann Int Med 108:491, 1988
59. Maduell F, Sanchez-Alcaraz A, Siguenza F, et al: Treatment of nephrotic syndrome associated with idiopathic rapidly progressive glomerulonephritis and cyclosporin A. J Clin Pharm Ther 18:59-62, 1993
60. Callis L, Vila A, Nieto J, Fortuny G: Effect of cyclosporin A on proteinuria in patients with Alport's syndrome. Pediatr Nephrol 6:140-144, 1992
61. Halevi R, Einstein B, Drukker A: Cyclosporin A in the treatment of infantile nephrotic syndrome. J Am Soc Nephrol 5:646, 1994